Scrip
2010 Scrip 100 - David Brennan juggling pharma and PhRMA
09 December 2009
Christopher Spillane
It was never going to be a quiet year for David Brennan. A slowing pipeline, neutral ratings from analysts and a recession were among the challenges that AstraZeneca's CEO addressed in 2009. Now he's fighting the industry's corner as the US market braces itself for healthcare...
Please Login to read the full article.
09 December 2009
Christopher Spillane
Please Login to read the full article.
RELATED CONTENT
NEWS
- US health reform bill: Senate's work may be done, but difficult issues on conference
- Senators see room for more PhRMA healthcare reform concessions in importation debate
- US Senate finance panel clears healthcare reform bill with new pharma fees
- US House reform bill requires government negotiation of Part D drug prices
COMMENT
Other Informa Comment
FEATURES
- GE Healthcare aims to end unpredictability in early drug research
- Debate for a new R&D model must start now
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
